Cargando…

INCESSANT PERICARDITIS AND CARDIAC TAMPONADE FOLLOWING THE BNT162B2 MRNA COVID-19 VACCINE

Detalles Bibliográficos
Autores principales:	Rodden, Diane, Ma, Gary, Phreaner, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2022
Materias:	Complex Clinical Cases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972377/ http://dx.doi.org/10.1016/S0735-1097(22)03316-2

Ejemplares similares

Incessant Pericarditis With Recurrent Cardiac Tamponade as the Manifestation of Autoimmune Polyglandular Syndrome Type II
por: Marinho, Ana V., et al.
Publicado: (2020)

RELAPSING PERICARDITIS FOLLOWING COVID-19 VACCINE
por: Ahmed, Mawada, et al.
Publicado: (2022)

SARS-COV-2 AND MRNA VACCINE-ASSOCIATED RECURRENT PERICARDITIS TREATED WITH RILONACEPT
por: Shell, John Clark, et al.
Publicado: (2023)

Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination
por: Goddard, Kristin, et al.
Publicado: (2022)

Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine
por: Ramírez-García, Almudena, et al.
Publicado: (2021)

A RARE CASE OF CONSTRICTIVE PERICARDITIS FOLLOWING COVID-19 EXPOSURE AND VACCINATION
por: Yousafzai, Osman K., et al.
Publicado: (2022)

Cardiac arrest following cardiac tamponade caused by mycosis fungoides malignant pericarditis
por: Sato, Shuku, et al.
Publicado: (2021)

DIAGNOSING PERICARDITIS DUE TO COVID-19 VACCINATION
por: Zektser, Yuliya, et al.
Publicado: (2022)

FULMINANT RECURRENT PERICARDITIS, POSSIBLY RELATED TO CORONAVIRUS VACCINATION. OR IS IT ?
por: Schwartzenberg, Shmuel, et al.
Publicado: (2022)

Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines
por: Naveed, Zaeema, et al.
Publicado: (2022)

COVID-19 INDUCED MYOPERICARDITIS AND CARDIAC TAMPONADE: A DIAGNOSTIC DILEMMA
por: Ebrahim, Mohammed
Publicado: (2022)

CONSTRICTIVE PERICARDITIS: A RARE COMPLICATION FOLLOWING COVID-19 INFECTION
por: Khattab, Mahmood, et al.
Publicado: (2022)

WHEN LESS IS MORE: PURULENT PERICARDITIS FOLLOWING COVID 19 PNEUMONIA
por: Tu, Xinhang, et al.
Publicado: (2022)

HEMORRHAGIC CARDIAC TAMPONADE IN A PATIENT WITH COVID-19 AND END STAGE RENAL DISEASE
por: Mirzaei, Mojtaba, et al.
Publicado: (2022)

COVID-19 FULMINANT MYOCARDITIS PROGRESSING TO CARDIAC TAMPONADE IN LESS THAN 24 HOURS
por: Ammar, Ali, et al.
Publicado: (2022)

An Uncommon Case of Incessant Tachycardia-induced Cardiomyopathy in a Child
por: Poghosyan, Hermine R., et al.
Publicado: (2018)

BNT162B2 MRNA BOOSTER VACCINE-RELATED PERICARDITIS: A CASE COMPLICATED BY PERICARDIAL AND PLEURAL EFFUSIONS
por: WHITE, ANESHA, et al.
Publicado: (2022)

STEMI FOLLOWING MRNA COVID-19 VACCINATION
por: Botros, Mina Booless, et al.
Publicado: (2022)

MYOCARDITIS FOLLOWING MRNA COVID-19 VACCINATION
por: Pant, Kailash, et al.
Publicado: (2023)

Hemodialysis-Related Pericarditis With Cardiac Tamponade
por: Watase, Hirara, et al.
Publicado: (2022)

EFFUSIVE CONSTRICTIVE PERICARDITIS IN THE SETTING OF RECURRENT COVID-19 INFECTION IN A VACCINATED PATIENT
por: Ahmed, Asmaa, et al.
Publicado: (2023)

Cardiac Tamponade: A Life-Threatening Sequelae of Pericarditis Following mRNA COVID-19 Vaccination (mCV)
por: Liang, D., et al.
Publicado: (2022)

EVOLOCUMAB TREATMENT FAILURE FOLLOWING COVID-19 MRNA VACCINATION
por: Park, Byung Joon, et al.
Publicado: (2022)

UREMIC PERICARDITIS IN A COVID-19 PATIENT
por: Sherif, Khaled, et al.
Publicado: (2021)

EFFUSIVE CONSTRICTIVE PERICARDITIS RELATED TO COVID 19
por: Pabba, Krishna, et al.
Publicado: (2022)

Incessant pericarditis following the second dose of SARS-CoV-2 mRNA vaccine successfully treated with anakinra: a case report
por: Conte, C, et al.
Publicado: (2022)

Medium-term outcomes of myocarditis and pericarditis following BNT162b2 vaccination among adolescents in Hong Kong
por: Chua, Gilbert T., et al.
Publicado: (2022)

Systematic review and meta-analysis of myocarditis and pericarditis in adolescents following COVID-19 BNT162b2 vaccination
por: Katoto, Patrick D. M. C., et al.
Publicado: (2023)

ACUTE PERICARDITIS AS THE INITIAL MANIFESTATION OF MULTISYSTEM INFLAMMATORY SYNDROME WITH SEVERE CARDIAC DYSFUNCTION IN A COVID-19 IGG POSITIVE PATIENT
por: Oglat, Hamza, et al.
Publicado: (2022)

Constrictive pericarditis following atrial fibrillation catheter ablation with cardiac tamponade
por: Fukasawa, Kohki, et al.
Publicado: (2021)

A Case of Actinomycosis Presenting as Purulent Pericarditis with Cardiac Tamponade
por: Tuck, Nicholas, et al.
Publicado: (2021)

Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination
por: Gouda, Wesam, et al.
Publicado: (2022)

Central serous chorioretinopathy following the BNT162b2 mRNA vaccine
por: Hanhart, J., et al.
Publicado: (2022)

The clinical course of patients with previous acute and recurrent pericarditis receiving the BNT162b2 vaccine
por: Wasserstrum, Yishay, et al.
Publicado: (2022)

Prominent J Waves and Ventricular Fibrillation Caused by Myocarditis and Pericarditis After BNT162b2 mRNA COVID-19 Vaccination
por: Uesako, Hayata, et al.
Publicado: (2022)

Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines
por: Abraham, Natalia, et al.
Publicado: (2022)

Tuberculous Pericarditis Presenting as Cardiac Tamponade: Role of Echocardiography
por: Khatun, Nazima, et al.
Publicado: (2023)

Uremic Pericarditis with Cardiac Tamponade in a Patient on Hemodialysis
por: Javed, Nismat, et al.
Publicado: (2023)

Safety of the BNT162b2 mRNA COVID-19 vaccine in patients with familial Mediterranean fever
por: Shechtman, Liran, et al.
Publicado: (2022)

Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders
por: Rosman, Yossi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tso36l0fb7oqia8vkghskt1gdj